Previous studies have shown that siRNA knockdown or pharmacologic inhibition of NOX4 promoted intra-tumoral CD8+ T-cell infiltration in many human cancer types and restored immunotherapy response induced by cancer-associated fibroblasts (CAFs) (43). The gene discussed is CD8A; the disease is cancer.